SCN2B
Basic information
Region (hg38): 11:118162806-118176639
Links
Phenotypes
GenCC
Source:
- Brugada syndrome (Limited), mode of inheritance: AD
- Brugada syndrome (Supportive), mode of inheritance: AD
- familial atrial fibrillation (Supportive), mode of inheritance: AD
- atrial fibrillation, familial, 14 (Moderate), mode of inheritance: AD
- atrial fibrillation, familial, 14 (Limited), mode of inheritance: Unknown
- atrial fibrillation, familial, 14 (Limited), mode of inheritance: AD
- Brugada syndrome 1 (Disputed Evidence), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Atrial fibrillation, familial 14 | AD | Cardiovascular | In Atrial fibrillation, surveillance (eg, with echocardiogram and electrocardiogram) may allow early management, which may be beneficial | Cardiovascular | 19808477 |
ClinVar
This is a list of variants' phenotypes submitted to
- Atrial_fibrillation,_familial,_14 (142 variants)
- Cardiovascular_phenotype (137 variants)
- not_provided (23 variants)
- not_specified (10 variants)
- SCN2B-related_disorder (3 variants)
- Primary_dilated_cardiomyopathy (1 variants)
- Variant_of_unknown_significance (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SCN2B gene is commonly pathogenic or not. These statistics are base on transcript: NM_000004588.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 62 | 63 | ||||
missense | 107 | 20 | 127 | |||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 3 | |||||
splice donor/acceptor (+/-2bp) | 2 | |||||
Total | 0 | 0 | 113 | 82 | 0 |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SCN2B | protein_coding | protein_coding | ENST00000278947 | 4 | 14723 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00171 | 0.723 | 125730 | 1 | 17 | 125748 | 0.0000716 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.317 | 120 | 130 | 0.922 | 0.00000875 | 1419 |
Missense in Polyphen | 40 | 51.537 | 0.77615 | 545 | ||
Synonymous | -0.765 | 63 | 55.7 | 1.13 | 0.00000400 | 425 |
Loss of Function | 0.827 | 5 | 7.43 | 0.673 | 3.25e-7 | 93 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000870 | 0.0000870 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000598 | 0.000598 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000353 | 0.0000264 |
Middle Eastern | 0.000598 | 0.000598 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Crucial in the assembly, expression, and functional modulation of the heterotrimeric complex of the sodium channel. The subunit beta-2 causes an increase in the plasma membrane surface area and in its folding into microvilli. Interacts with TNR may play a crucial role in clustering and regulation of activity of sodium channels at nodes of Ranvier (By similarity). {ECO:0000250}.;
- Disease
- DISEASE: Note=Genetic variations in SCN2B may be involved in Brugada syndrome (PubMed:23559163). This tachyarrhythmia is characterized by right bundle branch block and ST segment elevation on an electrocardiogram (ECG). It can cause the ventricles to beat so fast that the blood is prevented from circulating efficiently in the body. When this situation occurs, the individual will faint and may die in a few minutes if the heart is not reset. {ECO:0000269|PubMed:23559163}.;
- Pathway
- Antiarrhythmic Pathway, Pharmacodynamics;Developmental Biology;Phase 0 - rapid depolarisation;Cardiac conduction;Muscle contraction;Interaction between L1 and Ankyrins;L1CAM interactions;Axon guidance
(Consensus)
Recessive Scores
- pRec
- 0.133
Intolerance Scores
- loftool
- 0.268
- rvis_EVS
- -0.45
- rvis_percentile_EVS
- 24
Haploinsufficiency Scores
- pHI
- 0.214
- hipred
- N
- hipred_score
- 0.345
- ghis
- 0.707
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.248
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Scn2b
- Phenotype
- homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- chemical synaptic transmission;nervous system development;sodium ion transmembrane transport;response to pyrethroid;cardiac muscle contraction;regulation of atrial cardiac muscle cell membrane depolarization;cardiac muscle cell action potential involved in contraction;membrane depolarization during cardiac muscle cell action potential;regulation of heart rate by cardiac conduction;regulation of sodium ion transmembrane transporter activity
- Cellular component
- voltage-gated sodium channel complex
- Molecular function
- voltage-gated ion channel activity;sodium channel regulator activity;voltage-gated sodium channel activity involved in cardiac muscle cell action potential